News | November 14, 2024
AstraZeneca invests US$ 3.5 billion in R&D and manufacturing in US
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Advances clinical research capabilities with leading regulatory grade registries platform
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Subscribe To Our Newsletter & Stay Updated
